Meeting
2020 ASCO Quality Care Symposium
Impact of a built-in electronic medical record prompt on guideline-recommended prophylactic antiviral usage in patients with multiple myeloma receiving proteasome inhibitors.
Authors
Garrett Young
OneOncology, Nashville, TN
Garrett Young, Stacey McCullough, George Arrowsmith, Aaron J. Lyss, Stephen Matthew Schleicher, Natalie R. Dickson, Edward Arrowsmith
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
On-Demand Poster Session: Quality, Safety, and Implementation Science
Track
Quality, Safety, and Implementation Science
Sub Track
Standardization and Technology Efforts to Improve Safety
Citation
J Clin Oncol 38, 2020 (suppl 29; abstr 248)
DOI
10.1200/JCO.2020.38.29_suppl.248
Abstract #
248
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Impact of integrating standardized venous thromboembolism (VTE) prophylaxis orders for patients with multiple myeloma into an electronic health record (EHR).
First Author: Andrea Dickens
Poster
2023 ASCO Annual Meeting
Busulfan, melphalan, and carfilzomib (BuMelCar) conditioning for autologous stem cell transplant (ASCT) in multiple myeloma: Phase I/II data.
First Author: Joseph Allan Norton
Poster
2023 ASCO Annual Meeting
The role of private insurance characteristics in the out-of-pocket costs of patients with multiple myeloma.
First Author: Hamlet Gasoyan
Poster
2023 ASCO Annual Meeting
Identification of genes encoding targets associated with adverse events in multiple myeloma.
First Author: Xuan Xu